跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Heptavir Os
Approved
STANDARD
Heptavir Os
Hetero Labs Limited (Unit III)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a4095a05c9cae6a6
Company
Hetero Labs Limited (Unit III)
Type
Standard
Approval Details
Approval Id
a4095a05c9cae6a6
Drug Approval Philippines Name
Heptavir Os
Product Name
Heptavir Os
Registration Number
DR-XY48318
Brand Name
Heptavir Os
Generic Name
Lamivudine
Dosage Form
Oral Solution
Dosage Strength
10 mg/mL
Manufacturer
Hetero Labs Limited (Unit III)
Importer
Camber Pharmaceuticals, Inc.
Distributor
Camber Pharmaceuticals, Inc.
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Distributor Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
26 August 2022
Expiry Date
26 August 2025
Pharmacologic Category
Antiviral (Nucleoside/Nucleotide Reverse Transcriptase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a4095a05c9cae6a6
Type
Standard
Back to Philippines FDA Approvals
Heptavir Os - Philippines FDA Drug Approval Details